Guideline Archives - Page 14 of 16 - SAHPRA

Archive

This guideline is intended to provide recommendations to interested persons wishing to submit applications for the licensing of manufacturers, distributors and wholesalers, and registration of medical devices and IVDs. It represents the Authority’s current thinking on the safety, quality and performance of medical devices and...

This guideline provides a reference document detailing the regulatory requirements for reporting of an adverse event for a medical device (including an IVD) in South Africa and describes the information to be supplied to the South African Health Products Regulatory Authority (SAHPRA). This guideline is...

This guideline provides an outline of the principles and process to be followed in the donation of medicines, medical devices, and in vitro diagnostics (IVDs). The guideline applies to both people and entities wishing to make donations and the recipients of such donations. The South African...

This guideline is intended to provide recommendations to applicants wishing to submit applications for the registration of Complementary Medicines containing specified substances. In addition to this guideline, SAHPRA reserves the right to request any additional information to establish the safety, quality and efficacy of...

This guideline is intended to provide recommendations to applicants wishing to submit applications for the registration of Health Supplements. It represents the South African Health Product Regulatory Authority’s current thinking on the quality, safety, and efficacy of these medicines. It is not intended as an...

This document has been prepared to serve as guidance to stakeholders regarding the regulation pathway of Category D medicines ( complementary medicines registration. It represe...

This guideline is intended to provide recommendations to applicants wishing to submit new registration applications, as well as variations, for reliance review-based evaluation....

This document provides guidelines for the requirements of Good Manufacturing Practice (GMP) in South Africa. This guideline is not an exclusive approach. SAHPRA reserves the right to request any additional information to establish the safety, quality and efficacy of a medicine. SAHPRA may amend this...